Micron Technology Surpasses 1 Trillion Market Cap Following UBS Price Target Upgrade Bloom Energy Joins Leopold Aschenbrenners Top Portfolio as AI Fuel Cell Partnership Emerges Gorey Freight Pricing Model Sparks Business and Housing Concerns CLARITY Acts Potential Influence on XRPs LongTerm Outlook SpaceX Delays Starship Launch as Company Prepares for Landmark Share Sale Microsofts GitHub Faces Reliability Challenges Amid AI Coding Race Competition American Rebel Holdings Q1 2026 Earnings Negative EPS Highlights Ongoing Operational Headwinds Amplitech Group Inc Series B Right AMPGZ Q1 2026 Earnings EPS Misses Estimates Stock Gains 69 NTRSO Q1 2026 Earnings Strong EPS Beat Amid Cautious Market Sentiment Western Union WU Q1 2026 Earnings EPS Misses Estimates by a Wide Margin Shares Slide Fortis Inc FTS Q1 2026 Earnings Modest EPS Miss Amid Steady Utility Performance UnitedGuardian Inc UG Q2 2025 Earnings EPS of 014 Reported Amidst Stock Decline Fifth Era Acquisition Corp I Rights FERAR Faces Selling Pressure Tests Key Support at 028 BankUnited BKU Edges Lower in Quiet Session as Traders Eye Key Price Zones Lucid Diagnostics Rallies 7 as Shares Test Resistance Near 112 Lithium Americas LAC Slips 17 Hovers Near Key Support as Lithium Headwinds Persist Nocera Inc NCRA Surges 15 as Stock Tests Key Resistance at 027 Nuclear Startup Newcleo to Go Public on Nasdaq at 24 Billion Valuation WidePoint WYY Q1 2026 Earnings EPS Surprises Positively Revenue Not Disclosed Stock Declines 19 Dingdong DDL Edges Lower as Stock Holds Above Key Support Level CIMP Q1 2026 Earnings EPS Beats Estimates by 282 DNN Q1 2026 Earnings Widerthanexpected loss as uranium development costs mount ADPT Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Surprise TIGO Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines 33 GAP Q1 2026 Earnings EPS Slightly Misses Estimates Amid Challenging Retail Environment Nextpower Inc NXT Q1 2026 Earnings EPS Beat of 1316 Overshadowed by Stock Decline CLGN Q4 2025 Earnings EPS Misses Estimates as Biotech Continues PreRevenue Phase